Skip to main content
SpringerLink
Log in

Neuropathic Pain

  • Chapter
  • First Online:
Neurology

  • 2943 Accesses

Abstract

Neuropathic pain is a heterogenous condition that results from disorders that affect the central or peripheral nervous system. Herpes zoster results from reactivation of the zoster virus, and may result in postherpetic neuralgia, particularly in the elderly. There is no compelling evidence that antiviral therapy administered acutely during a bout of zoster reduces the risk of developing postherpetic neuralgia. The administration of the zoster vaccine may modestly reduce the risk of developing herpes zoster and postherpetic neuralgia, and anticonvulsant therapy is effective in reducing pain in patients who develop postherpetic neuralgia. Pain is a frequent manifestation of central nervous system disorders, and the prevalence of neuropathic pain following stroke is 12%. Pregabalin and tricyclic medications are effective in the treatment of central neuropathic pain.

Neuropathic pain is a potential, disabling manifestation of peripheral neuropathy. Diabetes mellitus is a major potential cause of peripheral neuropathy, and neuropathic pain may occur in as many as 26% of patients. Tricyclic antidepressant medications, pregabalin, and gabapentin are effective in reducing diabetic neuropathic pain. Furthermore, combination therapy using gabapentin and nortriptyline reduces diabetic neuropathic pain.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. Seattle, WA: IASP; 1994. p. 212.

    Google Scholar 

  2. Hall GC, Carroll D, McQuay HJ. Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002–2005. BMC Fam Pract. 2008;9:26.

    Google Scholar 

  3. Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136:380–7.

    Article  PubMed  Google Scholar 

  4. Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain. 2002;18:355–65.

    Article  PubMed  Google Scholar 

  5. Li Q, Yang J, Zhou M, Zhang Q, He L. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2009;4.

    Google Scholar 

  6. Sampathkumar P, Drage LA, Martin DP. Herpes Zoster (Shingles) and postherpetic Neuralgia. Mayo Clin Proc. 2009;84(3):274–80.

    Article  PubMed  Google Scholar 

  7. Yawn BP, Saddier P, Wollan P, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster introduction. Mayo Clin Proc. 2007;82(11):1341–9.

    Article  PubMed  Google Scholar 

  8. Yawn BP, Itzler RF, Wollan PC, Pellisier JM, Sy LS, Saddier P. Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc. 1009;84(9):787–94.

    Article  Google Scholar 

  9. Insinga RP, Itzler RF, Pellissier JP, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20(8):748–53.

    Article  PubMed  Google Scholar 

  10. Oxman MN et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271–84.

    Article  PubMed  CAS  Google Scholar 

  11. Crooks RJ, Jones DA, Fiddian AP. Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Scand J Infect Dis. 1991;80:62–8.

    CAS  Google Scholar 

  12. Wood MJ, Kay R, Dworkin RH. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 1996;22(2): 341–7.

    Article  PubMed  CAS  Google Scholar 

  13. Alper BS, Lewis PR. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? J Fam Pract. 2000;49(3):255–64.

    PubMed  CAS  Google Scholar 

  14. Khaliq W, Alam S, Puri NK. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev. 2009;3.

    Google Scholar 

  15. Wiffen PJ, Collins S, McQuay HJ, Carroll D, Jadad A, Moore RA. Anticonvulsant drugs for acute and chronic pain (Review). Cochrane Database Syst Rev. 2009;3.

    Google Scholar 

  16. Treeded RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–5.

    Article  Google Scholar 

  17. Andreson G, Vestergaard K, Ingeman-Nielson M, Staehelin Jensen T. Incidence of post-stroke pain. Pain. 1995;61:187–93.

    Article  Google Scholar 

  18. Appelros P. Prevalence and predictors of pain and fatigue after stroke: a population-based study. Int J Rehab Res. 2006;29:329–33.

    Article  Google Scholar 

  19. Kong KH, Woon VC, Yang SY. Prevalence of chronic pain and its impact on health-related quality of life in stroke survivors. Arch Phys Med Rehab. 2004;85:35–40.

    Article  Google Scholar 

  20. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults (Review). Cochrane Database Syst Rev. 2009;3.

    Google Scholar 

  21. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain (Review). Cochrane Database Syst Rev. 2007;4.

    Google Scholar 

  22. Centers for Disease Control and Prevention. Diabetes: Disabling, deadly, and on the rise. GA, USA:CDC; 2005.

    Google Scholar 

  23. Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell MD. Epidemiologic, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med. 2007;8(S2):S50–62.

    Google Scholar 

  24. Davies M, Williams R, Brophy S, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabet Care. 2006;29(7):1518–22.

    Article  Google Scholar 

  25. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes mellitus. NEJM. 1995;333:89–94.

    Article  PubMed  CAS  Google Scholar 

  26. Dieleman JP, Kerklaan J, Huygen FJPM, Bouma PAD, Sturkenboom MCJM. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain. 2008;137: 681–8.

    Article  PubMed  Google Scholar 

  27. Backonja M, Betdoun A, Edwards KR, Schwarz SI, Fonseca V, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA. 1998;280(21): 1831–6.

    Article  PubMed  CAS  Google Scholar 

  28. Gilron I, Bailey JM, Dongsheng T, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomized controlled crossover trial. Lancet. 2009;374:1252–61.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurology Department, EMG Laboratory, Mayo College of Medicine, Mayo Clinic, 13400 East Shea Blvd., Scottsdale, AZ, 85259, USA

    Brent P. Goodman MD

Authors
  1. Brent P. Goodman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brent P. Goodman MD .

Editor information

Editors and Affiliations

  1. London Health Sciences Centre, Dept. Clinical Neurosciences, University of Western Ontario, Windermere Road 339, London, N6A 5A5, Ontario, Canada

    Jorge G. Burneo

  2. , Neurology, Mayo Clinic Hospital, E. Mayo Blvd. 5777, Phoenix, 85054, Arizona, USA

    Bart M. Demaerschalk

  3. London Health Sciences Centre, Dept. Clinical Neurosciences, University of Western Ontario, Windermere Road 339, London, N6A 5A5, Ontario, Canada

    Mary E. Jenkins

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Goodman, B.P. (2012). Neuropathic Pain. In: Burneo, J., Demaerschalk, B., Jenkins, M. (eds) Neurology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-88555-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-88555-1_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-88554-4

  • Online ISBN: 978-0-387-88555-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation